GE医疗近日迎来其磁共振产品线的重大进展——新一代Signa磁共振技术获得美国食品药品监督管理局（FDA）批准。该技术旨在通过提升图像精准度和优化临床工作流程，推动医学影像诊断的效能突破。
GE医疗近日迎来其磁共振产品线的重大进展——新一代Signa磁共振技术获得美国食品药品监督管理局（FDA）批准。该技术旨在通过提升图像精准度和优化临床工作流程，推动医学影像诊断的效能突破。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.